Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-25 · accession 0000097745-25-000172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-26 | 2025-11-25 | TMO | Shafer Michael D | EVP | S - Sale+OE | $600.00 | -10.7K | 18.7K | -36% | -$6.43M |
| DM | 2025-11-26 | 2025-11-25 | TMO | Shafer Michael D | EVP | M - OptEx | $262.39 | +10.7K | 27.2K | +65% | +$2.81M |
| DM | 2025-11-26 | 2025-11-25 | TMO | Shafer Michael D | EVP | M - OptEx | $0.00 | -10.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-25 | S | D | 8,475 | $600.00 | 18,730.80 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-25 | M | A | 2,250 | $294.02 | 20,980.80 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-25 | M | A | 8,475 | $253.99 | 27,205.80 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-25 | S | D | 2,250 | $600.00 | 18,730.80 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 8,475 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 8,475 Common Stock | (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-11-25 | M | D | 2,250 | $0.00 | 0 | D | $294.02 · — to 2026-09-05 | 2,250 Common Stock | (F3) The option vested in four equal installments on September 5, 2020, 2021, 2022, and 2023. |